Your browser doesn't support javascript.
loading
Epicardial delivery of XC001 gene therapy for refractory angina coronary treatment (The EXACT Trial): Rationale, design, and clinical considerations.
Povsic, Thomas J; Henry, Timothy D; Ohman, E Magnus; Pepine, Carl J; Crystal, Ronald G; Rosengart, Todd K; Reinhardt, Rickey R; Dittrich, Howard C; Traverse, Jay H; Answini, Geoffrey A; Mokadam, Nahush A.
Afiliação
  • Povsic TJ; Program for Advanced Coronary Disease, Duke University Medical Center and Duke Clinical Research Institute, Durham, NC. Electronic address: Thomas.povsic@duke.edu.
  • Henry TD; The Carl and Edyth Lindner Center for Research and Education at The Christ Hospital, Cincinnati, OH.
  • Ohman EM; Program for Advanced Coronary Disease, Duke University Medical Center and Duke Clinical Research Institute, Durham, NC.
  • Pepine CJ; Division of Cardiovascular Medicine, University of Florida, Gainesville, FL.
  • Crystal RG; Department of Genetic Medicine, Weill Cornell Medicine, New York, NY.
  • Rosengart TK; Department of Surgery, Baylor College of Medicine, Houston, TX.
  • Reinhardt RR; XyloCor Therapeutics, Malvern, PA.
  • Dittrich HC; XyloCor Therapeutics, Malvern, PA.
  • Traverse JH; Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, MN.
  • Answini GA; Division of Cardiovascular Surgery, The Christ Hospital Physicians-Heart & Vascular, Cincinnati, OH.
  • Mokadam NA; Division of Cardiac Surgery, The Ohio State Wexner Medical Center, Columbus, OH.
Am Heart J ; 241: 38-49, 2021 11.
Article em En | MEDLINE | ID: mdl-34224684

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Terapia Genética / Fatores de Crescimento do Endotélio Vascular / Angina Pectoris Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Terapia Genética / Fatores de Crescimento do Endotélio Vascular / Angina Pectoris Idioma: En Ano de publicação: 2021 Tipo de documento: Article